Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
was more painful; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Tetanus vaccine with an associated reaction of pain (received tetanus shot and was painful) and Shingles vaccine with an associated reaction of pain (received 1st dose of Shingles vaccine with event pain for tolerance refer 1st dose case US2025AMR044144.). On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: was more painful). Rechallenge with Shingles vaccine was positive. The outcome of the pain was not reported. It was unknown if the reporter considered the pain to be related to Shingles vaccine. It was unknown if the company considered the pain to be related to Shingles vaccine. Linked case(s) involving the same patient: US2025AMR044144 Additional Information: GSK Receipt Date : 09-APR-2025 This case was reported by a patient via interactive digital media. The patient reported that he/she got the two shots of shingles and was more painful than a tetanus shot for him/her. The patient suggested that took it on a Friday so you have the weekend to recover.; Sender's Comments: US-GSK-US2025AMR044144:same patient dose 1